Navigation Links
New Stanford device could reduce surgical scarring
Date:5/23/2011

STANFORD, Calif. Researchers at Stanford University have developed a special wound dressing that they report was able to significantly reduce scar tissue caused by incisions.

Results of animal tests and of an early clinical trial of the dressing were "stunning," said Michael Longaker, MD, MBA, the Deane P. and Louise Mitchell Professor at the School of Medicine and senior author of a study that details the findings. "It was a surprisingly effective treatment."

The study will be published online May 23 in the Annals of Surgery.

After sutures are removed, the edges of a healing incision are pulled in different directions by the taut, surrounding skin, causing scar tissue to thicken and spread. The novel dressing, which the authors refer to as a "stress-shielding device," eliminates this tension and hence a considerable amount of scarring.

"This work actually started 20 years ago when I was an intern at Massachusetts General Hospital," said lead author Geoffrey Gurtner, MD, professor and associate chair of surgery. "I realized early on that we were not going to solve the problem of scarring with current surgical tools and techniques."

Co-author Reinhold Dauskardt, PhD, professor of materials science and engineering in the School of Engineering, recalled a meeting he had with Gurtner that launched the effort to create a stress-shielding device. "We were talking about our respective research," Dauskardt said. "Geoff had a lot of experience in wound healing and was thinking about factors that led to scarring. He said, 'If only we could keep in check the mechanical forces acting on the wound.' I had multiple programs on skin biomechanics and transdermal-drug delivery. I said, 'I think I can do that.'"

Dauskardt and his colleagues created the dressing in his lab. It is made of a thin and elastic silicone plastic that is stretched over the incision after sutures have been removed. The dressing sticks to the skin with the help of an adhesive. As it contracts, it provides uniform compression across the wound.

Scar tissue, which is less flexible than regular skin, can cause functional problems, such as limiting motion. Hair does not grow in a scar, and it doesn't have sweat glands. In addition, scars do not look like regular skin: They are often raised and have a pinkish hue. Many people consider them unattractive. Yet they are an unavoidable side effect of surgery. Every year in the United States, more than 50 million incisions are created during operations. Meanwhile, hundreds of millions of people already have scars that they would prefer to eliminate. Current scar-removal techniques, including surgical excision, steroid injections and laser therapy, are generally expensive, painful or simply not very effective, the authors say.

The researchers predicted the dressing will be used not only to reduce scarring from incisions, but also to make the surgical revision of existing scars a more appealing option; the second scar would be much less visible, if visible at all.

In pigs, which have skin similar to that of humans, the area of scars caused by roughly 1-inch incisions was reduced six-fold by the stress-shielding device, compared to pigs in a control group with the same-sized incisions, the study said. The stress-shielded wounds "demonstrated nearly scarless closure" eight weeks after sutures had been removed.

The researchers also tested the device on roughly 1-by-1.5-inch excisions a wound mimicking the kind caused by scar removal and found that "stress shielding dramatically decreased scar area" compared to unshielded wounds of the same size. "The device seemed to promote regenerative-like repair rather than scar formation," the authors wrote.

Next, the researchers tested the device on nine female patients who had undergone abdominoplasties (tummy tucks). Given the quantity of tissue removed during this elective surgery, a tremendous amount of tension occurred across the wound after closure. (Scars from these procedures are typically wide and thick.) Longaker said he and his colleagues deliberately chose to test the dressing on incisions closed with high tension: If the dressing could reduce scarring in such cases, it would surely work on any other kind of incision.

One side of the abdomen-wide incision on each patient was treated with the stress-shielding dressing; the other half was not. A panel of three plastic surgeons unaffiliated with the research, as well as a panel of three people not in the medical profession, acted as judges. On a 100-point scale, the lay panel scored the appearance of stress-shielded wounds an average of 13.2 points higher than the control wounds. The expert panel scored the scar appearance of the treated incisions 39.2 points higher. In both of these analyses, the difference between the treated side and the control side were highly significant, the researchers said.

But they noted that some of the wounds demonstrated more dramatic improvement than others. They speculate this may have been due to differences in the amount of tension present in the dressings when they were applied to the wounds. In any case, the researchers cautioned that this was a preliminary clinical study designed only to show "proof of principle in humans."

"Larger clinical trials are being planned to include greater ethnic diversity within the patient population and to determine the optimal range of stress-shielding forces for anatomic region- and dimension-specific wounds," the authors wrote.


'/>"/>

Contact: John Sanford
jsanford@stanfordmed.org
650-723-8309
Stanford University Medical Center
Source:Eurekalert

Related medicine news :

1. Stanford discoveries about tumor-suppressing protein could help to reduce treatment side effects
2. Stanford research casts sober light on Russias mortality crisis
3. Pitt-Stanford research suggests aimless proteins crucial to disease
4. Stanford researchers discover molecular determinant of cell identity
5. New gene regions identified that predispose people to heart attacks, Stanford scientists say
6. Evidence lacking for widespread use of costly antipsychotic drugs, says Stanford researcher
7. Stanford researchers first to turn normal cells into 3-D cancers in tissue culture dishes
8. Certain cancer therapies success depends on presence of immune cell, Stanford study shows in mice
9. Need a study break to refresh? Maybe not, say Stanford researchers
10. Stanford-led study disproves link between genetic variant, risk of coronary artery disease
11. Wider statin use could be cost-effective preventive measure, Stanford study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... ... in Suffolk”: a story of love, secrets, and mystery. “Christmas in Suffolk” is ... works in a daycare and looks for inspiration in the local coffee shop as ... Seymour’s new book is an adventure of love and secrets. , After ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... “Knowledge is ... be guided by faith. “Knowledge is God’s Lighthouse” is the creation of published author, ... cookbooks, novels, and poetry collections. , “I have been writing since high school ...
(Date:1/20/2017)... ... January 20, 2017 , ... “God's Miracle Man: Against All Odds”: ... creation of published author, Keith C. A. Tucker, son of Minister Delores Pinnock and ... pastured by Reverend Mark Hardy , “While sitting up in bed, I felt a ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... Aerolib Learning Management System: an On-demand E-learning system for Clinical and Regulatory ... Administration that is based on Aerolib`s successful education methodology of Disease Specific ...
(Date:1/19/2017)... Florida (PRWEB) , ... January 19, 2017 , ... ... dollar 5,000 SF expansion and facility enhancement of their 503A compounding pharmacy located ... meet the growing demand of physicians and patients throughout the United States for ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... January 19, 2017 According to a study ... is set to witness a CAGR of 6.5% during the forecast ... will continue to be the leading market for cryotherapy globally ... ... emphasizing on ensuring affordable and adequate supply of gas in order ...
(Date:1/19/2017)... 2017  Abaxis, Inc. (NasdaqGS: ABAX ), ... and consumables for the medical and veterinary markets worldwide, ... results for the third quarter fiscal year 2017, ended ... p.m. ET on Thursday, January 26, 2017.  The Company ... year 2017 after the market closes on Thursday, January ...
(Date:1/19/2017)... Fla. , Jan. 19, 2017  Sensus ... medical device company specializing in the treatment of ... as keloids, with superficial radiation therapy, today announced ... full year 2016 financial results on Thursday, February 2, ... Company will hold a conference call with the ...
Breaking Medicine Technology: